Mahmoud Hassouba, MD
Plastic and Reconstructive Surgery · Memphis, TNNPI 1437534682
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Polynovo North America LLC at 27.6% of the total.
Across 138 payments — averaging $45.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Polynovo North America LLC$2K
- Polymedics Innovations Inc.$1K
- Smith+Nephew$582
- Vericel Corporation$514
- Kerecis Limited$468
- Avita Medical Americas, LLC$412
- plus $1K from 14 others
Across 2 payments — averaging $13,596 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avita Medical Americas, LLC$20K
- Kerecis Limited$8K
What the payments were for
- Food & beverage$6,03597%
- Gifts$2133%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Polynovo North America LLC | 28 | $1,724 |
| Polymedics Innovations Inc. | 11 | $1,131 |
| Smith+Nephew | 19 | $582 |
| Vericel Corporation | 17 | $514 |
| Kerecis Limited | 4 | $468 |
| Avita Medical Americas, LLC | 16 | $412 |
| Medline Industries LP | 10 | $406 |
| Biotissue Holdings Inc. | 5 | $376 |
| Merck | 6 | $119 |
| Aroa Biosurgery Incorporated | 1 | $83 |
| Acera Surgical, Inc. | 4 | $82 |
| Integra Lifesciences Corporation | 3 | $79 |
| La Jolla Pharmaceutical Company | 3 | $56 |
| Urgo Medical North America, LLC | 3 | $53 |
| AbbVie | 2 | $41 |
| Baxter Healthcare | 1 | $31 |
| Trevena, Inc. | 2 | $29 |
| Vertex | 1 | $25 |
| Shionogi Inc | 1 | $21 |
| Medela LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$1,277
- Novosorb BTM$1,073
- Kerecis Omega3 SurgiClose$738
- Oasis$245
- NexoBrid$208
- Kerecis Omega3 GraftGuide$152
- RECELL$127
- ACTICOAT 4" X 4"$117
- COLLAGENASE SANTYL$117
- Versajet$117
How this compares
$6,248 in reported general payments places this provider in the 75th percentile of 77 plastic and reconstructive surgery providers in Tennessee.
See all plastic and reconstructive surgery providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Memphis
- William HickersonMemphis$833K
- Robert WallaceMemphis$21K
- Roberto LachicaMemphis$13K
- Ammar MahmoodMemphis$9K
- Thao WolbertMemphis$4K
- Dani KruchevskyMemphis$2K
- Edward LuceMemphis$2K
- Daniel HatefNashville$673K
- Mark BrzezienskiChattanooga$32K
- Earl LettMount Juliet$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.